We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVI Global Trust Regulatory News (AGT)

Share Price Information for AVI Global Trust (AGT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 237.00
Bid: 236.00
Ask: 237.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.424%)
Open: 236.00
High: 237.00
Low: 235.50
Prev. Close: 237.00
AGT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monthly Factsheet

9 Aug 2023 14:32

RNS Number : 8385I
AVI Global Trust PLC
09 August 2023
 

 

AVI GLOBAL TRUST PLC

 

Monthly Update

 

AVI Global Trust plc (the "Company") presents its Update, reporting performance figures for the month ended 31 July 2023.

 

This Monthly Newsletter is available on the Company's website at:

https://www.assetvalueinvestors.com/content/uploads/2023/08/AGT-JULY-2023.pdf

 

 

Performance Total Return

 

This investment management report relates to performance figures to 31 July 2023.

 

Total Return (£)

Month

Calendar Yr

to date

1Y

3Y

5Y

10Y

AGT NAV

4.4%

6.5%

6.3%

51.4%

44.0%

133.8%

MSCI ACWI Ex US

2.8%

6.5%

7.3%

25.3%

23.2%

86.8%

MSCI ACWI

2.4%

10.4%

6.8%

37.3%

51.5%

169.8%

 

 

Manager's Comment

 

AVI Global Trust (AGT)'s NAV increased by +4.4% in July.

 

Schibsted (+12%) and Aker (+6%) were the two largest positive contributors (with a further fillip from a +5% appreciation of NOK against Sterling), followed by our Japanese Banks basket and IAC (+9%) - both of which we discuss below. Godrej Industries was the only notable detractor (-8%).

 

In last year's annual report we detailed how 2022 was something of an annus horribilis for IAC. The company suffered a dual shock of significant NAV weakness and discount widening as it was caught in the perfect storm of a rising cost of capital and deteriorating fundamentals. This made it your company's largest detractor in FY22.

 

In 2023 the shares have started to make a recovery, rising +57%, with a +25% increase in our estimated NAV boosted by a narrowing of the discount from 45% to 31%. Having added to the position by about a third in early January, averaging down our cost base, IAC has been one our best performers this year. NAV growth has been almost exclusively driven by MGM (37% of NAV) and Angi (18% of NAV), shares in which have returned +51%, and +65%, respectively.

 

In IAC CEO Joey Levin's quarterly letter at the start of the year, he talked of a "back to basics" strategy. This has clearly been evidenced at Angi, the homeservices marketplace. Since becoming CEO of Angi a little under a year ago Joey has steadied the ship. Measures to reduce the cost structure have been implemented, with a -14% year-on-year reduction in sales team headcount and -50% reduction in capex in Q1. He has started to simplify the product offering and ambition, reducing losses from Services (from -$19m to -$2m as they exit un-economic offerings). Arguably this is the "easy" bit and the next stage of showing the business can successfully drive top-line growth is the hard bit - with the jury very much still out as to whether this is possible. That said, the "easy" bit is not to be sniffed at - after all the company churned through three CEOs in five years who couldn't do it! With earnings starting to ramp up, we believe this creates a base from which value can be grown and extracted. At the current $2.3bn enterprise value - which equates to 1.3x trailing sales and ~10x 2025 EBITDA -we believe the business could be of interest to financial buyers given the attractive cash generative nature of the core Ads & Leads business and room for cost cutting from non-core areas. This would be an attractive outcome for IAC shareholders, giving the company significant capital to allocate. Alternatively, although sceptical, we remain open minded to Joey Levin continuing to drive fundamental improvements, re-igniting growth and margins - something to which the market doesn't appear to be assigning a high probability.

 

Turning to Dotdash Meredith (11% of NAV) - the digital media company that was established in 2021 when IAC's Dotdash acquired the storied media brands of the Meredith Corporation - there are also signs of improvement. Whilst 2022 had always been billed as a transition year, a deterioration in ad markets, compounded by a much slower and more complex than anticipated integration, meant the first twelve months of ownership were ones to forget. In 2023 the integration issues are now behind them, with the focus now solely on navigating a challenging macro environment. In aggregate, management describe the ad market as being in a state of "stable weakness", albeit with significant variation by category. We remain somewhat cautious on the heavy lifting that the second half of the year will have to do for Dotdash Meredith to reach management guidance of $250-300m adjusted EBITDA but, given the high incremental margins the business earns, are excited about the prospects for meaningful recovery in earnings and growth over the medium term - validating the acquisition.

 

Despite the strong share price performance, the stub remains lowly valued, at an implied $1.5bn (inclusive of Dotdash Meredith level debt). At this price you are paying 5.6x this years depressed EBITDA for Dotdash Meredith and receiving every else for free.

 

History shows that IAC shares perform well when the market wakes up and starts valuing the "for free" part. In this vein we are particularly excited about Turo (9% of NAV), a car sharing marketplace where guests can rent cars from a community of hosts akin to Airbnb. The business has many of the hallmark's IAC look for: 1) large addressable market with long-growth runway; 2) network effect protected competitive position; 3) capital light business model with attractive unit economics. Earlier this year IAC increased its stake in the company from 26% to 31% at an implied $2.3bn valuation (whilst they also own a warrant which could see their stake increase to a further 10%). Recently there have been rumours that the company - which filed an S1 in early 2022 - might be looking to IPO, with the rally in equity markets having created a more hospitable environment. We believe this is exactly the kind of event that can help drive IAC shares higher and combined with the prospects for improved fundamental performance and earnings growth at Dotdash Meredith and Angi, makes us optimistic about prospective returns. Indeed, management seem to share our optimism and have become more aggressive at deploying the company's balance sheet, buying back 3.7% of the outstanding shares between February and early May (at an annualised rate of c.18%).

 

Earlier this year we built a small basket of four Japanese regional banks (£37m at cost). Such companies have been textbook value traps over the last decade-plus: optically incredibly cheap - but for a reason. Cash and securities that dwarf their market caps, but with management teams unwilling to improve capital efficiency; and margins constrained in the zero-interest rate world of Yield Curve Control.

 

On both fronts we felt the prospects for change were underpriced by the market - with increasing activist pressure (as evidenced by recent proposals at the Bank of Kyoto AGM) and a seemingly inevitable requirement for changes to Japanese monetary policy in-light of evidence of sustained inflation.

 

At the end of July, the Bank of Japan (BOJ) did indeed adjust its policy stance, widening the rate at which it will purchase government bonds to 1.0% from 0.5% previously. Whilst the Bank were keen to stress the extent to which this isn't an abandonment of YCC - in bank speak they are technically moving from a "rigid" 0.5% limit to a "reference" limit - it is a sign of the changing inflationary and monetary policy environment in Japan.

 

Over the month shares in the four banks we hold rose between +13% and +24%, adding +62bps to AGT's NAV. In total since inception the basket has generated a ROI of +25% (IRR: +58%). Although the depreciation of the Japanese Yen has resulted in a significantly more modest +9% ROI in Sterling terms, we see scope for this Yen headwind to reverse. Indeed, there is an element of synthetic leverage to our position in the banks in so far as higher yields should beget higher bank share prices and a stronger Yen.

 

We believe our basket of banks - which collectively have net cash and securities totalling 133% of their market caps - are fundamentally cheap with catalysts for both improved shareholder returns and fundamental performance. To put that in our vernacular: we see room for both NAV growth and discount narrowing.

 

Contributors / Detractors (in GBP)

 

Largest Contributors

1- month contribution

bps

% Weight

Schibsted ASA 'B'

116

7.7

Aker ASA

63

6.2

IAC

34

3.7

KKR

30

6.3

Pershing Square Holdings

28

5.3

 

Largest Detractors

1- month contribution

bps

% Weight

Godrej Industries

-28

2.7

SK Square/Short SK Hynix

-9

2.0

D'Ieteren

-9

4.0

Nihon Kohden

-7

3.7

Christian Dior

-6

4.2

 

 

Link Company Matters Limited

Corporate Secretary

 

09 August 2023

 

LEI: 213800QUODCLWWRVI968

 

The content of the Company's web-pages and the content of any website or pages which may be accessed through hyperlinks on the Company's web-pages, other than the content of the Newsletter referred to above, is neither incorporated into nor forms part of the above announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCUPUUWRUPWGWB
Date   Source Headline
1st May 20241:39 pmRNSNet Asset Value(s)
1st May 20247:00 amRNSTotal Voting Rights
30th Apr 202412:30 pmRNSNet Asset Value(s)
29th Apr 20241:34 pmRNSNet Asset Value(s)
26th Apr 202412:06 pmRNSNet Asset Value(s)
25th Apr 20241:57 pmRNSNet Asset Value(s)
24th Apr 202412:34 pmRNSNet Asset Value(s)
23rd Apr 20241:00 pmRNSNet Asset Value(s)
22nd Apr 202412:54 pmRNSNet Asset Value(s)
19th Apr 20245:35 pmRNSTransaction in Own Shares
19th Apr 20243:39 pmRNSNet Asset Value(s)
19th Apr 20247:00 amRNSCompliance with Market Abuse Regulation
18th Apr 20245:40 pmRNSTransaction in Own Shares
18th Apr 202412:18 pmRNSNet Asset Value(s)
17th Apr 202412:24 pmRNSNet Asset Value(s)
16th Apr 202412:31 pmRNSNet Asset Value(s)
15th Apr 202412:44 pmRNSNet Asset Value(s)
12th Apr 20245:30 pmRNSTransaction in Own Shares
12th Apr 20242:09 pmRNSNet Asset Value(s)
11th Apr 20245:49 pmRNSTransaction in Own Shares
11th Apr 202412:59 pmRNSNet Asset Value(s)
10th Apr 20245:44 pmRNSTransaction in Own Shares
10th Apr 20241:01 pmRNSNet Asset Value(s)
9th Apr 20245:40 pmRNSTransaction in Own Shares
9th Apr 20243:48 pmRNSMonthly Factsheet
9th Apr 202412:20 pmRNSNet Asset Value(s)
9th Apr 202411:56 amRNSDirector/PDMR Shareholding
8th Apr 20244:58 pmRNSDirector/PDMR Shareholding
8th Apr 202412:58 pmRNSNet Asset Value(s)
8th Apr 202412:53 pmRNSAppointment of Corporate Broker
8th Apr 202412:39 pmRNSListing Rule 15.6.8
5th Apr 20241:57 pmRNSNet Asset Value(s)
4th Apr 20245:32 pmRNSTransaction in Own Shares
4th Apr 20241:13 pmRNSNet Asset Value(s)
3rd Apr 20245:32 pmRNSTransaction in Own Shares
3rd Apr 20242:28 pmRNSNet Asset Value(s)
3rd Apr 20247:00 amRNSKepler Trust Intelligence: New Research
2nd Apr 20245:30 pmRNSTransaction in Own Shares
2nd Apr 20244:32 pmRNSNet Asset Value(s)
2nd Apr 202412:31 pmRNSTotal Voting Rights
28th Mar 20245:32 pmRNSTransaction in Own Shares
28th Mar 20242:08 pmRNSNet Asset Value(s)
27th Mar 20245:48 pmRNSTransaction in Own Shares
27th Mar 20243:27 pmRNSNet Asset Value(s)
26th Mar 20245:23 pmRNSTransaction in Own Shares
26th Mar 20242:12 pmRNSNet Asset Value(s)
25th Mar 20245:29 pmRNSTransaction in Own Shares
25th Mar 20242:00 pmRNSNet Asset Value(s)
22nd Mar 20245:33 pmRNSTransaction in Own Shares
22nd Mar 20242:08 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.